<?xml version="1.0" encoding="UTF-8"?>
<p>The exploitation of a naïve llama antibody repertoire resulted in the screening of rabies virus glycoprotein specific VHH, which later led to the generation of homogenous pentavalent multimers called combodies, possessing increased virus-neutralizing capability, following the fusion with coiled–coil peptides from human cartilage oligomeric matrix protein [
 <xref rid="B66-antibodies-09-00021" ref-type="bibr">66</xref>]. In dogs, the therapeutic application of rAbs is mainly restricted to cancer and inflammatory disturbances [
 <xref rid="B72-antibodies-09-00021" ref-type="bibr">72</xref>]. 
</p>
